LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET 2019-2027

Lifesciences | Diagnostic & Biotechnology

LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET 2019-2027

Market By Gender, End-use And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research has estimated the Latin America infertility (testing and treatment) market to show an upward trend in terms of revenue and grow with a CAGR of 7.27% in the forecast years from 2019 to 2027.

Countries included in the Latin America infertility (testing and treatment) market are:

•           Brazil

•           Mexico

•           Latin America

Report scope can be customized per your requirements. Request For Customization

In-vitro fertilization is the most commonly used technique for infertility treatments. The infertility-affected couples adopt IVF to combine the eggs and sperm in the lab, after which the fertilized embryo is placed into the uterus. IVF techniques have shown high success rates as they allow a controlled interaction of eggs and sperm. Medications raise the number of mature eggs a woman can produce at a single time. Doctors may examine each of the matured embryos to conclude which ones will most probably result in pregnancy. While IVF may not be appropriate for all couples or individuals, it offers a high possibility of pregnancy in a short period of time.

The declining fertility rates over the last few decades have given rise to a burgeoning market for infertility (testing and treatment) in Latin America. There has been an improvement in infertility treatment due to dedicated research and development, and doctors can now choose one embryo to transplant in the uterus and leave the rest. This technological advancement enables doctors to avoid multiple pregnancies.

IVF procedures are costly and a large number of infertile couples still do not have access to this mode of treatment, which is one of the biggest restraints faced by the industry. The cost of IVF treatment is dependent upon the treatment type as well as the age of the woman who is seeking the treatment. The cost for a woman below 35 years is less; as the woman’s age increases, the cost of the IVF treatment also increases. IVF treatments have shown low success rates in women aged over 40 years. Also, the cost of treatment offered to them is the highest.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    INFERTILITY (TESTING AND TREATMENT) MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHTS

2.2.1.   IVF DOMINATES THE FEMALE TREATMENT MARKET

2.2.2.   OXIDATIVE STRESS ANALYSIS IS THE FASTEST GROWING MALE INFERTILITY TESTING MARKET

2.3. PORTER’S FIVE FORCE ANALYSIS

2.3.1.   THREAT OF NEW ENTRANTS

2.3.2.   THREAT OF SUBSTITUTE

2.3.3.   BARGAINING POWER OF BUYERS

2.3.4.   BARGAINING POWER OF SUPPLIERS

2.3.5.   INTENSITY OF COMPETITIVE RIVALRY

2.4. KEY IMPACT ANALYSIS

2.4.1.   TREATMENT OPTIONS

2.4.2.   QUALITY OF MEDICAL PROCEDURES

2.4.3.   PRICE OF TREATMENTS

2.4.4.   SHIFT TOWARDS MEDICAL TOURISM

2.4.5.   REIMBURSEMENT

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. INDUSTRY COMPONENTS

2.7.1.   RAW MATERIAL PROCUREMENT

2.7.2.   MANUFACTURING

2.7.3.   SUPPLY LOGISTICS

2.7.4.   DISTRIBUTION CHANNELS

2.7.5.   END-USERS

2.8. REGULATORY FRAMEWORK

2.9. MARKET DRIVERS

2.9.1.   RISE IN INFERTILITY AND TREATMENT AWARENESS

2.9.2.   MEDICAL TOURISM IN FERTILITY TREATMENTS

2.9.3.   SURROGACY LAWS ARE GETTING MORE DEFINED

2.9.4.   HEALTHCARE ADVANCES HAVE FINE-TUNED FERTILITY TREATMENT

2.9.5.   INCREASING EFFECTIVENESS OF TREATMENTS

2.9.6.   HEALTHIER DONOR EGGS

2.9.7.   INTRODUCTION OF NEW TESTING DEVICES

2.10.            MARKET RESTRAINTS

2.10.1.                TREATMENT PROCEDURE OUT OF REACH FOR MANY DUE TO HIGH COSTS

2.10.2.                COUNTRY-WISE REGULATORY ISSUES

2.11.            MARKET OPPORTUNITIES

2.11.1.                REDUCING THE COST OF TREATMENT TO MAKE IT MORE ACCESSIBLE

2.11.2.                IVF ATTRACTING INVESTMENTS FROM PRIVATE EQUITY INVESTORS

2.11.3.                DIY TESTING INCREASING ACCESS AND REDUCING COST

2.12.            MARKET CHALLENGES

2.12.1.                INFERTILITY CONSIDERED A SOCIAL TABOO AMONGST MEN

2.12.2.                PERILS OF MULTIPLE PREGNANCIES

2.12.3.                TRADITIONAL TREATMENTS USED WIDELY AS AN ALTERNATIVE FOR INFERTILITY TREATMENTS

3.    INFERTILITY (TESTING AND TREATMENT) MARKET OUTLOOK - BY GENDER

3.1. MALE GENDER

3.1.1.   TESTING

3.1.1.1.      DNA FRAGMENTATION

3.1.1.2.      OXIDATIVE STRESS ANALYSIS

3.1.1.3.      SPERM PENETRATION ASSAY

3.1.1.4.      COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)

3.1.1.5.      SPERM AGGLUTINATION

3.1.1.6.      MICROSCOPIC EXAMINATION

3.1.1.7.      OTHERS

3.1.2.   TREATMENT

3.2. FEMALE GENDER

3.2.1.   FEMALE INFERTILITY TESTING

3.2.1.1.      OVULATION TESTING

3.2.1.2.      HYSTEROSALPINGOGRAPHY

3.2.1.3.      LAPAROSCOPY

3.2.1.4.      TRANSVAGINAL ULTRASOUND

3.2.1.5.      OVARIAN RESERVE TESTING

3.2.1.6.      HORMONAL LEVEL TESTING

3.2.1.7.      OTHERS

3.2.2.   TREATMENT

4.    INFERTILITY (TESTING AND TREATMENT) MARKET OUTLOOK - BY END-USE

4.1. FERTILITY CLINICS

4.2. HOSPITALS

4.3. SURGICAL CENTERS

4.4. CLINICAL RESEARCH INSTITUTES

5.    INFERTILITY (TESTING AND TREATMENT) MARKET - REGIONAL OUTLOOK

5.1.      BRAZIL

5.2.      MEXICO

5.3.      REST OF LATIN AMERICA

6.    COMPETITIVE LANDSCAPE

6.1. ANDROLOGY SOLUTIONS

6.2. ENDO PHARMACEUTICALS

6.3. PROGYNY

6.4. FERRING PHARMACEUTICALS

6.5. GENEA

6.6. HALOTECH DNA

6.7. IRVINE SCIENTIFIC

6.8. MERCK

6.9. ORIGIO

6.10.            OVASCIENCE

6.11.            VITROLIFE AB        

6.12.            THERMO FISHER SCIENTIFIC, INC.

6.13.            THE COOPER COMPANIES, INC.

6.14.            QUEST DIAGNOSTIC

6.15.            ESCO MICRO PTE. LTD.

7.    RESEARCH METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.1.1.   OBJECTIVES OF STUDY

7.2. SOURCES OF DATA

7.2.1.   PRIMARY DATA SOURCES

7.2.2.   SECONDARY DATA SOURCES

7.3. RESEARCH METHODOLOGY

7.3.1.   EVALUATION OF PROPOSED MARKET

7.3.2.   IDENTIFICATION OF DATA SOURCES

7.3.3.   ASSESSMENT OF MARKET DETERMINANTS

7.3.4.   DATA COLLECTION

7.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1:       LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 2:       MARKET ATTRACTIVENESS INDEX

TABLE 3:       VENDOR SCORECARD

TABLE 4:       REGULATORY FRAMEWORK

TABLE 5:       AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS

TABLE 6:       LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, 2019-2027 (IN $ MILLION)

TABLE 7:       LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY GENDER, 2019-2027 (IN $ MILLION)

TABLE 8:       LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY MALE GENDER, 2019-2027 (IN $ MILLION)

TABLE 9:       LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY MALE INFERTILITY TESTING, 2019-2027 (IN $ MILLION)

TABLE 10:     LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY FEMALE GENDER, 2019-2027 (IN $ MILLION)

TABLE 11:     LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY FEMALE INFERTILITY TESTING, 2019-2027 (IN $ MILLION)

TABLE 12:     LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY END-USE, 2019-2027 (IN $ MILLION)

List of Figures

FIGURE 1:     LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY END-USER, 2018 & 2027 (IN %)

FIGURE 2:     PORTER’S FIVE FORCE ANALYSIS

FIGURE 3:     KEY BUYING IMPACT ANALYSIS

FIGURE 4:     INDUSTRY COMPONENTS

FIGURE 5:     MAJOR FERTILITY TREATMENT DESTINATION RANKING

FIGURE 6:     CLINICAL ALGORITHM FOR THE EVALUATION OF INFERTILE WOMAN

FIGURE 7:     RATE OF MULTIPLE DELIVERIES

FIGURE 8:     LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY MALE GENDER, 2019-2027 (IN $ MILLION)

FIGURE 9:     LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY TESTING, 2019-2027 (IN $ MILLION)

FIGURE 10:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY DNA FRAGMENTATION, 2019-2027 (IN $ MILLION)

FIGURE 11:  CAUSES OF SPERM DNA FRAGMENTATION

FIGURE 12:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY OXIDATIVE STRESS ANALYSIS, 2019-2027 (IN $ MILLION)

FIGURE 13:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY SPERM PENETRATION ASSAY, 2019-2027 (IN $ MILLION)

FIGURE 14:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS, 2019-2027 (IN $ MILLION)

FIGURE 15:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY SPERM AGGLUTINATION, 2019-2027 (IN $ MILLION)

FIGURE 16:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY MICROSCOPIC EXAMINATION, 2019-2027 (IN $ MILLION)

FIGURE 17:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)

FIGURE 18:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY TREATMENT, 2019-2027 (IN $ MILLION)

FIGURE 19:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY FEMALE GENDER, 2019-2027 (IN $ MILLION)

FIGURE 20:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY FEMALE INFERTILITY TESTING, 2019-2027 (IN $ MILLION)

FIGURE 21:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY OVULATION TESTING, 2019-2027 (IN $ MILLION)

FIGURE 22:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY HYSTEROSALPINGOGRAPHY, 2019-2027 (IN $ MILLION)

FIGURE 23:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY LAPAROSCOPY, 2019-2027 (IN $ MILLION)

FIGURE 24:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY TRANSVAGINAL ULTRASOUND, 2019-2027 (IN $ MILLION)

FIGURE 25:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY OVARIAN RESERVE TESTING, 2019-2027 (IN $ MILLION)

FIGURE 26:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY HORMONAL LEVEL TESTING, 2019-2027 (IN $ MILLION)

FIGURE 27:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)

FIGURE 28:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY FEMALE INFERTILITY TREATMENT, 2019-2027 (IN $ MILLION)

FIGURE 29:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY FERTILITY CLINICS, 2019-2027 (IN $ MILLION)

FIGURE 30:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY HOSPITALS, 2019-2027 (IN $ MILLION)

FIGURE 31:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY SURGICAL CENTERS, 2019-2027 (IN $ MILLION)

FIGURE 32:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, BY CLINICAL RESEARCH INSTITUTES, 2019-2027 (IN $ MILLION)

FIGURE 33:  LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)

FIGURE 34:  BRAZIL INFERTILITY (TESTING AND TREATMENT) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 35:  MEXICO INFERTILITY (TESTING AND TREATMENT) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 36:  REST OF LATIN AMERICA INFERTILITY (TESTING AND TREATMENT) MARKET, 2019-2027 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;